


Healthcare Industry NewsFeed
HSMN NewsFeed - 1 Aug 2024
Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases
Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases
HSMN NewsFeed - 30 Jul 2024
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
